Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom van Wezel

Showing results (151-160 of 212) with videos related to

Pageof 22
Sort By:
Plos Genetics|September 24, 2010
Allelic variation at the 8q23.3 colorectal cancer risk locus functions as a cis-acting regulator of EIF3HAlan M Pittman, Silvia Naranjo, Sanni E Jalava, et al.
The Journal of Experimental Medicine|August 21, 2013
DNA repair genes are selectively mutated in diffuse large B cell lymphomasNoel F C C de Miranda, Roujun Peng, Konstantinos Georgiou, et al.
Journal of Gastroenterology|November 3, 2022
Loss of bone morphogenetic protein signaling in fibroblasts results in CXCL12-driven serrated polyp developmentSarah Ouahoud, Barbara Florien Westendorp, Philip Willen Voorneveld, et al.
Journal of the National Cancer Institute|April 29, 2014
Re: Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesisBen Kinnersley, Stephan Buch, Sergi Castellví-Bel, et al.
International Journal of Cancer|September 19, 2012
Combined analysis of three Lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriersBente A Talseth-Palmer, Juul T Wijnen, Ingvild S Brenne, et al.
Gastroenterology|May 15, 2018
Molecular Background of Colorectal Tumors From Patients With Lynch Syndrome Associated With Germline Variants in PMS2Sanne W Ten Broeke, Tom C van Bavel, Anne M L Jansen, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 11, 2011
PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosisArantza Fariña Sarasqueta, Eliane C M Zeestraten, Tom van Wezel, et al.
Nature Genetics|June 29, 2002
Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancersClaudia A L Ruivenkamp, Tom van Wezel, Carlo Zanon, et al.
BMC Genomics|October 18, 2005
Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profilesElza C de Bruin, Simone van de Pas, Esther H Lips, et al.
Gastroenterology|May 18, 2017
Statin Use After Diagnosis of Colon Cancer and Patient SurvivalPhilip W Voorneveld, Marlies S Reimers, Esther Bastiaannet, et al.
Pageof 22

Showing results (151-160 of 212) with videos related to

Sort By:
Pageof 22
Plos Genetics|September 24, 2010
Allelic variation at the 8q23.3 colorectal cancer risk locus functions as a cis-acting regulator of EIF3HAlan M Pittman, Silvia Naranjo, Sanni E Jalava, et al.
The Journal of Experimental Medicine|August 21, 2013
DNA repair genes are selectively mutated in diffuse large B cell lymphomasNoel F C C de Miranda, Roujun Peng, Konstantinos Georgiou, et al.
Journal of Gastroenterology|November 3, 2022
Loss of bone morphogenetic protein signaling in fibroblasts results in CXCL12-driven serrated polyp developmentSarah Ouahoud, Barbara Florien Westendorp, Philip Willen Voorneveld, et al.
Journal of the National Cancer Institute|April 29, 2014
Re: Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesisBen Kinnersley, Stephan Buch, Sergi Castellví-Bel, et al.
International Journal of Cancer|September 19, 2012
Combined analysis of three Lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriersBente A Talseth-Palmer, Juul T Wijnen, Ingvild S Brenne, et al.
Gastroenterology|May 15, 2018
Molecular Background of Colorectal Tumors From Patients With Lynch Syndrome Associated With Germline Variants in PMS2Sanne W Ten Broeke, Tom C van Bavel, Anne M L Jansen, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 11, 2011
PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosisArantza Fariña Sarasqueta, Eliane C M Zeestraten, Tom van Wezel, et al.
Nature Genetics|June 29, 2002
Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancersClaudia A L Ruivenkamp, Tom van Wezel, Carlo Zanon, et al.
BMC Genomics|October 18, 2005
Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profilesElza C de Bruin, Simone van de Pas, Esther H Lips, et al.
Gastroenterology|May 18, 2017
Statin Use After Diagnosis of Colon Cancer and Patient SurvivalPhilip W Voorneveld, Marlies S Reimers, Esther Bastiaannet, et al.
Pageof 22